Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Physician
Patient
Health Care Practitioner
Pharma / Biotech Industry
Other
Topics:
Ophthalmology
•
Uveitis and Ocular Immunology
How do you manage checkpoint inhibitor-associated Vogt-Koyanagi-Harada (VKH) disease in patients who have poorly controlled diabetes?
Related Questions
What is your approach to antiviral treatment of HSV acute retinal necrosis?
How would you approach the management of dry corneal melt in a patient requiring high dose systemic steroids and no apparent underlying systemic autoimmune disease?
When would you consider using selective laser trabeculoplasty (SLT) for managing uveitic glaucoma?
How do you treat idiopathic acute anterior uveitis that recurs immediately after a course of topical corticosteroids?
How do you decide between initiating systemic immunosuppressive therapy versus controlling the uveitis with local treatment in a patient with HLA-B27 positive uveitis and a history of spondyloarthropathy?
How do you approach perioperative steroids for a quiescent uveitis patient undergoing cataract surgery?
How would you approach management of nodular scleritis in the setting of suspected GCA?
How do you approach the management of recurrent episcleritis in a patient with RA that is otherwise well-controlled?
How do you manage cystoid macular edema (CME) in patients with steroid-induced intraocular hypertension that is resistant to topical treatments?
How do you approach the management of bilateral non-infectious uveitis in the pediatric population?
